White matter measures are near normal in controlled HIV infection except in those with cognitive impairment and longer HIV duration

LA Cysique, JR Soares, G Geng, M Scarpetta… - Journal of …, 2017 - Springer
LA Cysique, JR Soares, G Geng, M Scarpetta, K Moffat, M Green, BJ Brew, RG Henry, C Rae
Journal of neurovirology, 2017Springer
The objective of the current study was to quantify the degree of white matter (WM)
abnormalities in chronic and virally suppressed HIV-infected (HIV+) persons while carefully
taking into account demographic and disease factors. Diffusion tensor imaging (DTI) was
conducted in 40 HIV− and 82 HIV+ men with comparable demographics and life style
factors. The HIV+ sample was clinically stable with successful viral control. Diffusion was
measured across 32 non-colinear directions with ab-value of 1000 s/mm 2; fractional …
Abstract
The objective of the current study was to quantify the degree of white matter (WM) abnormalities in chronic and virally suppressed HIV-infected (HIV+) persons while carefully taking into account demographic and disease factors. Diffusion tensor imaging (DTI) was conducted in 40 HIV− and 82 HIV+ men with comparable demographics and life style factors. The HIV+ sample was clinically stable with successful viral control. Diffusion was measured across 32 non-colinear directions with a b-value of 1000 s/mm2; fractional anisotropy (FA) and mean diffusivity (MD) maps were quantified with Itrack IDL. Using the ENIGMA DTI protocol, FA and MD values were extracted for each participant and in 11 skeleton regions of interest (SROI) from standard labels in the JHU ICBM-81 atlas covering major striato-frontal and parietal tracks. We found no major differences in FA and MD values across the 11 SROI between study groups. Within the HIV+ sample, we found that a higher CNS penetrating antiretroviral treatment, higher current CD4+ T cell count, and immune recovery from the nadir CD4+ T cell count were associated with increased FA and decreased MD (p < 0.05–0.006), while HIV duration, symptomatic, and asymptomatic cognitive impairment were associated with decreased FA and increased MD (p < 0.01–0.004). Stability of HIV treatment and antiretroviral CNS penetration efficiency in addition to current and historical immune recovery were related to higher FA and lower MD (p = 0.04–p < 0.01). In conclusion, WM DTI measures are near normal except for patients with neurocognitive impairment and longer HIV disease duration.
Springer